🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 82 of 151

  1. Mesenchymal stem cells from adipose tissue

    Lxo Ireland Designated Activity Company

    Critical Limb Ischemia

    phase 2 other completed

    1 trial

  2. Mesenchymal stem cells, Suspension and solvent for suspension for injection

    Disc Medicine

    Systemic Sclerosis

    phase 2 small molecule active

    1 trial

  3. Metformin

    United Therapeutics Europe Ltd

    C9orf72 Amyotrophic Lateral Sclerosis (ALS)

    phase 2 small molecule active

    1 trial

  4. Metformin

    United Therapeutics Europe Ltd

    Polycystic Kidney, Autosomal Dominant

    phase 2 small molecule completed

    1 trial

  5. Metformin + Standard of Care

    United Therapeutics Europe Ltd

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule active

    1 trial

  6. Metformin Hydrochloride ER

    Atrium Therapeutics

    Sarcoma Metastatic

    phase 2 small molecule active

    1 trial

  7. Metformin Zentiva 500 mg Filmtabletten

    The George Institute

    Multidrug rezistant pulmonary tuberculosis

    phase 2 small molecule active

    1 trial

  8. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  9. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Intoxication

    phase 2 small molecule active

    1 trial

  10. Methotrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Central Nervous System Lymphoma

    phase 2 small molecule active

    1 trial

  11. Methotrexate tablets

    The First People's Hospital of Lianyungang

    Solid Tumors

    phase 2 small molecule active

    1 trial

  12. Methylhydroxypropylcellulose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dry Eye Disease

    phase 2 small molecule active

    1 trial

  13. Methylphenidate + SPD503 (Guanfacine hydrochloride)

    Takeda

    Attention Deficit Disorder With Hyperactivity

    phase 2 small molecule completed

    1 trial

  14. Metronidazole

    Teva Pharma GmbH

    Bacterial Vaginosis

    phase 2 small molecule completed

    1 trial

  15. Metronidazole 500 mg / 100 ml Intravenous Infusion, Metronidazole 500mg/100ml Solution for Infusion, Aztreonam and Avibactam (1.5g/0.5g) Powder for Concentrate for Solution for Infusion, Metronidazole

    Pfizer Australia Pty Ltd

    Sepsis, Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment, Complicated Urinary Tract Infection, Blood Stream Infection, Hospital-acquired pneumonia or ventilator-associated pneumonia, Complicated Intra-abdominal Infection

    phase 2 small molecule active

    1 trial

  16. Mezagitamab

    Takeda

    Relapsed/Refractory

    phase 2 small molecule completed

    1 trial

  17. Mibavademab

    Regeneron UK Limited

    Functional Hypothalamic Amenorrhea (FHA)

    phase 2 small molecule active

    1 trial

  18. Micronized DHACM 40 mg

    United Therapeutics Europe Ltd

    Knee Osteoarthritis

    phase 2 mab terminated

    1 trial

  19. Micronized Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  20. Midazolam

    United Therapeutics Europe Ltd

    Stress Disorders, Post-Traumatic

    phase 2 small molecule completed

    1 trial

  21. Midazolam 1 mg, Psilocybine 5 mg

    s.r.o.

    Stable Ischemic Heart Disease

    phase 2 small molecule active

    1 trial

  22. Midazolam-ratiopharm® 2 mg/ml orale Lösung, JNJ-42756493, JNJ-42756493, Metformin HEXAL 1000 mg Filmtabletten, JNJ-42756493

    Janssen-Cilag International N.V.

    Urothelial cancer

    phase 2 small molecule active

    1 trial

  23. Midostaurin

    Novartis Pharmaceuticals

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  24. Mifamurtide

    Takeda

    Osteosarcoma

    phase 2 small molecule terminated

    1 trial

  25. Mifepristone

    CORCEPT THERAPEUTICS INC

    Weight-Gain Prevention

    phase 2 small molecule completed

    1 trial

  26. Mifepristone

    CORCEPT THERAPEUTICS INC

    Central Adrenal Insufficiency

    phase 2 small molecule terminated

    1 trial

  27. Mifepristone

    CORCEPT THERAPEUTICS INC

    Alzheimer's Disease

    phase 2 small molecule terminated

    1 trial

  28. Mifepristone

    CORCEPT THERAPEUTICS INC

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule terminated

    1 trial

  29. Mifepristone 1200 mg daily

    CORCEPT THERAPEUTICS INC

    Treatment-resistant PTSD

    phase 2 small molecule active

    1 trial

  30. Milrinone

    Stoke Therapeutics

    Valvular Stenosis

    phase 2 small molecule completed

    1 trial

  31. Mind-Body Bridging Program

    United Therapeutics Europe Ltd

    Sleep Disturbance

    phase 2 other completed

    1 trial

  32. Mindfulness Based Relapse Prevention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 2 other completed

    1 trial

  33. Mineral-enriched powder

    Disc Medicine

    Iron Deficiency

    phase 2 other completed

    1 trial

  34. Minocycline Hydrochloride

    United Therapeutics Europe Ltd

    Acute Pain

    phase 2 small molecule completed

    1 trial

  35. Miransertib

    Merck KGaA, Darmstadt, Germany

    PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome

    phase 2 small molecule terminated

    1 trial

  36. Miricorilant

    CORCEPT THERAPEUTICS INC

    Antipsychotic-induced Weight Gain (AIWG)

    phase 2 small molecule completed

    1 trial

  37. Miricorilant

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 2 small molecule active

    3 trials

  38. Miricorilant (Cohort A)

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 2 small molecule active

    1 trial

  39. Miricorlilant

    CORCEPT THERAPEUTICS INC

    Antipsychotic-induced Weight Gain (AIWG)

    phase 2 small molecule completed

    1 trial

  40. Mirikizumab - Intravenous (IV)

    Eli Lilly and Company

    Colitis, Ulcerative

    phase 2 small molecule active

    1 trial

  41. Mirtazapine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  42. Mirtazapine

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule completed

    1 trial

  43. Mirtazapine 15 MG Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  44. Mitapivat

    Agios Netherlands B.V.

    Anemia

    phase 2 small molecule active

    1 trial

  45. Mitomycin C

    AEON Biopharma

    Glaucoma

    phase 2 small molecule completed

    1 trial

  46. Mitomycin C

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 small molecule active

    1 trial

  47. Mitomycin C

    HALOZYME THERAPEUTICS, INC.

    Bladder Cancer

    phase 2 small molecule completed

    1 trial

  48. Mitoxantrone Hydrochloride Liposome

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.